Morgan Stanley (NYSE:MS) shares, rose in value, with the stock price down by -0.77% to the previous day’s close as strong demand from buyers drove the stock to $92.28.
Actively observing the price movement in the last trading, the stock closed the session at $93.00. The value of beta (5-year monthly) was 1.40 whereas the PE ratio was 17.84 over 12-month period. Referring to stock’s 52-week performance, its high was $95.57, and the low was $69.42. On the whole, MS has fluctuated by 3.53% over the past month.
With the market capitalization of Morgan Stanley currently standing at about $150.90 billion, investors are eagerly awaiting this quarter’s results, scheduled for Apr 16, 2024. The company’s Forward Dividend Ratio is 3.33, with its dividend yield at 3.60%. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be $1.68, which is expected to increase to $1.67 for fiscal year $6.4 and then to about $7.33 by fiscal year 2025. Data indicates that the EPS growth is expected to be 20.30% in 2025, while the next year’s EPS growth is forecast to be 14.50%.
Analysts have estimated the company’s revenue for the quarter at $14.43 billion, with a low estimate of $13.69 billion and a high estimate of $15.09 billion. According to the average forecast, sales growth in current quarter could jump up 3.60%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $56.64 billion, representing an increase of 4.60% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that MS’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium term indicators have put the stock in the category of 100% Buy while long term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 2.23, with the price of MS currently trading nearly 2.42% and 4.93% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 58.10, while the 7-day volatility ratio is showing 1.77% which for the 30-day chart, stands at 2.00%. Furthermore, Morgan Stanley (MS)’s beta value is 1.41, and its average true range (ATR) is 1.85.
A comparison of Morgan Stanley (MS) with its peers suggests the former has fared considerably weaker in the market. MS showed an intraday change of -0.77% in last session, and over the past year, it grew by 5.87%%.
Data on historical trading for Morgan Stanley (NYSE:MS) indicates that the trading volumes over the past 10 days have averaged 6.48 million and over the past 3 months, they’ve averaged 8.84 million. According to company’s latest data on outstanding shares, there are 1.63 billion shares outstanding.
Nearly 23.35% of Morgan Stanley’s shares belong to company insiders and institutional investors own 62.46% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 16.39 million shares as on Mar 15, 2024, resulting in a short ratio of 1.69. According to the data, the short interest in Morgan Stanley (MS) stood at 1.00% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 14.59 million. The stock has fallen by -1.04% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MS stock heading into the next quarter.
